Health Care Distributors

JP Morgan has published a research report on McKesson Corporation (NYSE: MCK) after the Veteran's Affairs House Committee hearing took place this morning. In the report, JP Morgan writes, "The revised VA Solicitation submitted on January 9, 2012 included pricing requests for certain generic...

Shares of McKesson (NYSE: MCK) are up more than 5% today after the company reported positive earnings yesterday. The company reported that revenues for the third quarter ended December 31, 2011 were up 9% to $30.8 billion compared to $28.2 billion a year ago. On the basis of U.S. generally...

Deutsche Bank maintains its Buy rating on McKesson (NYSE: MCK) following a strong earnings report from the company, and lowers its price target by $2 to $90 a share on general renewal pressures. Deutsche Bank says, "We reiterate our Buy rating on MCK following a strong earnings report as well as...

US stock futures are higher this morning, ahead of earnings reports from major companies. Futures for the Dow Jones Industrial Average surged 66 points to 12,668.00 and S&P 500 index futures rose 6.90 points to 1,315.80. Nasdaq 100 futures gained 14.00 points to 2,476.00. US stocks closed...

Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc (NYSE: PFE) to report its Q4 profit at $0.47 per share on revenue of $16.61 billion. PFE shares gained 0.56% to $21.70 in after-hours trading. RadioShack Corp (NYSE: RSH) issued a weak fourth-quarter...

McKesson Corporation (NYSE: MCK) announced adjusted earnings of $1.40 per share, or $300 million, a jump of nearly 100% from last year's profits of $155 million, or 60 cents a share. The company's revenue also jumped, reaching $30.84 billion. Analysts expected results of $1.37 per share. The...

Shares of McKesson (NYSE: MCK) are trading higher in the after-hours following the release of the company's Q3 earnings results. Currently, shares are higher by 0.39%, trading at $79.00; they ended the regular session lower by 0.78%, at $78.69. McKesson reported Q3 EPS of $1.40 on revenues of $30...

McKesson Corporation (NYSE: MCK) today announced that it has signed a definitive agreement to purchase Drug Trading Company Limited, the independent banner business of Katz Group Canada Inc., and Medicine Shoppe Canada Inc., the franchise business of Katz Group. Katz Group is a privately-owned...

US stock futures are lower this morning, as investors are awaiting a European Union summit. Futures for the Dow Jones Industrial Average dropped 76 points to 12,538.00 and S&P 500 index futures fell 8.50 points to 1,304.00. Nasdaq 100 futures dipped 16.25 points to 2,440.00. US stocks closed...

Actuate Corporation (NASDAQ: BIRT) is expected to post its Q4 EPS at $0.15 on revenue of $35.84 million. Gannett Co Inc (NYSE: GCI) is projected to report its Q4 earnings at $0.70 per share on revenue of $1.39 billion. Wolverine World Wide Inc (NYSE: WWW) is projected to report its Q4 earnings at...

Citigroup reiterates its Buy rating on McKesson (NYSE: MCK) and lowers its target price to $99 from $101 as it trims estimates to reflect layoffs and product transitioning. Citigroup says, “We expect McKesson to take charges related to employee layoffs and product transitioning over the next...

Citigroup has lowered the price target on Mckesson Corporation (NYSE: MCK) from $101 to $99 and maintains its Buy rating.

Auriga maintains its Buy rating and $95 target price on McKesson (NYSE: MCK) as the company looks to invest $1 billion in health IT. Auriga says, “Better Health is a corporate communications platform encompassing four broad areas – improving outcomes through integrated core financial and...

Wednesday, November 9, 2011 This is your Benzinga news summary and trader's outlook covering headlines from overnight and today's pre-market session. Benzinga's Top News General Motors (NYSE: GM) Reports Q3 EPS $1.03 vs $0.96 Est; Revenues $36.7B vs $36.66B Est Italian 2-Year, 3-Year, 5-Year,...

Goldman Sachs has added McKesson Corporation (NYSE: MCK) to its Conviction Buy List in place of AmerisourceBergen (NYSE: ABC), which has subsequently been removed. Goldman Sachs remains Buy-rated on ABC.